Form Health Reviews Metformin
Used alongside incretin therapy for glycemic indications, and as an early rung for members whose presentation warrants it.
Sold as Glucophage · Reviewed September 19, 2026
What “Adjunct” means here
Available and used, but not the centre of the protocol — typically alongside or after another agent.
The pairing
How Form Health handles Metformin
These are the vendor-specific mechanics that determine what this molecule actually costs you and whether members stay on it long enough to benefit.
- Access status
- Adjunct
- Gating
- Clinical indication.
- Prescribes directly
- Yes
- Step therapy
- Yes
- Prior authorization
- Yes
- Titration protocol
- Physician-led with obesity-medicine board certification required for all prescribers
- Off-ramp
- Physician-directed dose reduction with structured maintenance follow-up
- Care team
- Board-certified obesity medicine physicians, Registered dietitians, Nurse practitioners
Ask Form Health this
What proportion of members are maintained without incretin therapy at 12 months?
Watch out
Ask about prescriber capacity in your geography. Board-certified obesity medicine is a genuinely scarce specialty.
The molecule
Metformin in one page
Not a GLP-1, and not a weight-loss drug — but the first rung of nearly every credible step-therapy protocol, and effectively free. How a vendor uses metformin tells you whether its cost discipline is real.
Clinical profile
- Drug class
- Biguanide
- Brand names
- Glucophage — Type 2 diabetes
- Mechanism
- Reduces hepatic glucose production and improves insulin sensitivity. Weight effect is modest and secondary to the glycemic effect.
- Administration
- Oral, daily, usually with an extended-release formulation to improve tolerability.
- Titration
- Gradual escalation over several weeks, primarily to manage gastrointestinal tolerability.
- Typical result
- Modest weight reduction — typically low single digits as a percentage — alongside meaningful glycemic improvement in appropriate patients.
- Generic available
- Yes
Known side effects
- Gastrointestinal effects, substantially reduced by extended-release formulations
- Long-term B12 depletion warranting periodic monitoring
- Lactic acidosis, rare and largely confined to renal impairment
What benefits teams need to know
A useful test of vendor honesty
Every vendor lists metformin. Far fewer can show you what share of their population is maintained on it without escalating. Ask for that number — it separates vendors with a step-therapy protocol from vendors with a step-therapy slide.
It does not compete with GLP-1s on weight
Metformin is not an alternative to incretin therapy for a member who needs substantial reduction. Its role is identifying the members who never needed the expensive drug, not substituting for it in those who do.
Alternatives
Other vendors and Metformin
Same molecule, materially different access rules. The status column is where the cost difference lives.
| Vendor | Access | Score | PMPM |
|---|---|---|---|
| Virta Health Metabolic specialist | First-line | 8.7 | $40–$95 |
| Twin Health Metabolic specialist | First-line | 7.8 | $55–$120 |
| Found Full-service clinical | First-line | 7.6 | $45–$85 |
| Vida Health Full-service clinical | First-line | 7.5 | $38–$78 |
| Teladoc Health Navigation & orchestration | First-line | 7.4 | $18–$44 |
| 9amHealth Metabolic specialist | First-line | 7.3 | $34–$72 |
Same vendor
Form Health across the formulary
How this vendor positions each molecule tells you more about its cost discipline than any single review does.
First-line, prescribed exclusively by physicians board-certified in obesity medicine — the highest clinical bar of any vendor evaluated. Protocol discipline shows up in real-world results tracking unusually close to trial benchmarks.
First-line alongside semaglutide, selected on clinical grounds by an obesity-medicine specialist rather than by formulary default. Physician-directed dose reduction is built into the maintenance plan.
Genuinely used rather than merely listed. Form's formulary breadth and specialist prescribers make it one of the few vendors that will place a member on a cheaper agent when it is clinically appropriate.